Charles Cazanave

Summary

Affiliation: CHU de Bordeaux
Country: France

Publications

  1. doi request reprint Mycoplasma genitalium, an emerging sexually transmitted pathogen
    C Cazanave
    USC Infections Humaines à Mycoplasmes et Chlamydiae, Universite de Bordeaux, 33076 Bordeaux Cedex, France
    Med Mal Infect 42:381-92. 2012
  2. ncbi request reprint Reduced bone mineral density in HIV-infected patients: prevalence and associated factors
    Charles Cazanave
    Fédération de maladies infectieuses et tropicales, Hopital Pellegrin, Place A, Raba Léon, 33076 Bordeaux Cedex, France
    AIDS 22:395-402. 2008
  3. pmc Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort
    Mojgan Hessamfar
    INSERM U897 and CIC EC7, Universite de Bordeaux, Institut de Santé Publique Epidémiologie et Développement ISPED, Bordeaux, France Centre Hospitalier Universitaire CHU Bordeaux, Coordination Régionale de la lutte contre l infection à VIH COREVIH Aquitaine, Bordeaux, France CHU Bordeaux, Service de Medecine Interne et Maladies Infectieuses, Bordeaux, France
    PLoS ONE 9:e102671. 2014
  4. doi request reprint Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
    Frédéric Antoine Dauchy
    Services de Maladies Infectieuses et Tropicales and COREVIH, Hopital Pellegrin, CHU de Bordeaux, Université Bordeaux Segalen, Bordeaux, France
    Kidney Int 80:302-9. 2011
  5. ncbi request reprint Candida prosthetic infections: case series and literature review
    Herve Dutronc
    Service de Maladies Infectieuses et Tropicales, Hopital Pellegrin, Universite Victor Segalen Bordeaux 2, CHU de Bordeaux, Bordeaux, France
    Scand J Infect Dis 42:890-5. 2010
  6. ncbi request reprint Molecular characterization of non-B HIV type 1 isolates from patients of a department of infectious diseases, University Hospital of Bordeaux, France, 1989-2009
    François Charles Javaugue
    Laboratoire de Virologie, Hopital Pellegrin, Centre Hospitalier Universitaire de Bordeaux et CNRS UMR, France
    AIDS Res Hum Retroviruses 28:1124-30. 2012
  7. pmc Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Stephane De Wit
    Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium
    Diabetes Care 31:1224-9. 2008

Collaborators

Detail Information

Publications7

  1. doi request reprint Mycoplasma genitalium, an emerging sexually transmitted pathogen
    C Cazanave
    USC Infections Humaines à Mycoplasmes et Chlamydiae, Universite de Bordeaux, 33076 Bordeaux Cedex, France
    Med Mal Infect 42:381-92. 2012
    ..All this raises the issue of the most appropriate therapeutic management and requires drafting diagnostic and therapeutic guidelines for the treatment of M. genitalium infections...
  2. ncbi request reprint Reduced bone mineral density in HIV-infected patients: prevalence and associated factors
    Charles Cazanave
    Fédération de maladies infectieuses et tropicales, Hopital Pellegrin, Place A, Raba Léon, 33076 Bordeaux Cedex, France
    AIDS 22:395-402. 2008
    ..There is a high prevalence of bone demineralization among HIV-infected patients but mechanisms of alteration of bone turnover are still unclear and it is thought to be multifactorial...
  3. pmc Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort
    Mojgan Hessamfar
    INSERM U897 and CIC EC7, Universite de Bordeaux, Institut de Santé Publique Epidémiologie et Développement ISPED, Bordeaux, France Centre Hospitalier Universitaire CHU Bordeaux, Coordination Régionale de la lutte contre l infection à VIH COREVIH Aquitaine, Bordeaux, France CHU Bordeaux, Service de Medecine Interne et Maladies Infectieuses, Bordeaux, France
    PLoS ONE 9:e102671. 2014
    ..To describe trends and determinants of severe morbidity in HIV-infected women and men...
  4. doi request reprint Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
    Frédéric Antoine Dauchy
    Services de Maladies Infectieuses et Tropicales and COREVIH, Hopital Pellegrin, CHU de Bordeaux, Université Bordeaux Segalen, Bordeaux, France
    Kidney Int 80:302-9. 2011
    ..22) or had been discontinued (OR 11.49). Thus, cumulative exposure to TDF and/or atazanavir was associated with an increased risk of PRTD, with concern about its reversibility in patients with HIV...
  5. ncbi request reprint Candida prosthetic infections: case series and literature review
    Herve Dutronc
    Service de Maladies Infectieuses et Tropicales, Hopital Pellegrin, Universite Victor Segalen Bordeaux 2, CHU de Bordeaux, Bordeaux, France
    Scand J Infect Dis 42:890-5. 2010
    ..The benchmark antifungal therapies remain amphotericin B and/or fluconazole...
  6. ncbi request reprint Molecular characterization of non-B HIV type 1 isolates from patients of a department of infectious diseases, University Hospital of Bordeaux, France, 1989-2009
    François Charles Javaugue
    Laboratoire de Virologie, Hopital Pellegrin, Centre Hospitalier Universitaire de Bordeaux et CNRS UMR, France
    AIDS Res Hum Retroviruses 28:1124-30. 2012
    ..Recombinant form CRF02_AG was the most frequent subtype (38%) among a highly diverse viral background since 19 subtypes and CRFs have been characterized with a maximal diversity observed in the past decade...
  7. pmc Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Stephane De Wit
    Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium
    Diabetes Care 31:1224-9. 2008
    ....